Global Liposomes Drug Delivery Market Size, Status and Forecast 2022

Published: May, 2017 | Pages: 106 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report studies the global Liposomes Drug Delivery market, analyzes and researches the Liposomes Drug Delivery development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

•	Johnson & Johnson
•	Gilead Sciences
•	Luye Pharma
•	Sun Pharmaceutical
•	Pacira
•	Fudan-Zhangjiang
•	Sigma-Tau Group
•	Teva Pharmaceutical
•	CSPC
•	Novartis
•	Crucell
•	Celsion Corporation
•	Kingond Pharm
•	Shanghai New Asia
•	Spectrum Pharmaceuticals

Market segment by Regions/Countries, this report covers

•	United States
•	EU
•	Japan
•	China
•	India
•	Southeast Asia

Market segment by Application, Liposomes Drug Delivery can be split into

•	Fungal Infection Therapy
•	Cancer Therapy

If you have any special requirements, please let us know and we will offer you the report as you want

 Table of Contents

Global Liposomes Drug Delivery Market Size, Status and Forecast 2022

1 Industry Overview of Liposomes Drug Delivery
    1.1  Liposomes Drug Delivery Market Overview
        1.1.1 Liposomes Drug Delivery Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Liposomes Drug Delivery Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Liposomes Drug Delivery Market by End Users/Application
        1.3.1 Fungal Infection Therapy
        1.3.2 Cancer Therapy

2 Global Liposomes Drug Delivery Competition Analysis by Players
    2.1 Liposomes Drug Delivery Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Johnson & Johnson
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Gilead Sciences
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Luye Pharma
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Sun Pharmaceutical
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Pacira
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Fudan-Zhangjiang
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Sigma-Tau Group
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Teva Pharmaceutical
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 CSPC
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Novartis
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Liposomes Drug Delivery Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Crucell
    3.12 Celsion Corporation
    3.13 Kingond Pharm
    3.14 Shanghai New Asia
    3.15 Spectrum Pharmaceuticals

4 Global Liposomes Drug Delivery Market Size by Application (2012-2017)
    4.1 Global Liposomes Drug Delivery Market Size by Application (2012-2017)
    4.2 Potential Application of Liposomes Drug Delivery in Future
    4.3 Top Consumer/End Users of Liposomes Drug Delivery

5 United States Liposomes Drug Delivery Development Status and Outlook
    5.1 United States Liposomes Drug Delivery Market Size (2012-2017)
    5.2 United States Liposomes Drug Delivery Market Size and Market Share by Players (2016 and 2017)

6 EU Liposomes Drug Delivery Development Status and Outlook
    6.1 EU Liposomes Drug Delivery Market Size (2012-2017)
    6.2 EU Liposomes Drug Delivery Market Size and Market Share by Players (2016 and 2017)

7 Japan Liposomes Drug Delivery Development Status and Outlook
    7.1 Japan Liposomes Drug Delivery Market Size (2012-2017)
    7.2 Japan Liposomes Drug Delivery Market Size and Market Share by Players (2016 and 2017)

8 China Liposomes Drug Delivery Development Status and Outlook
    8.1 China Liposomes Drug Delivery Market Size (2012-2017)
    8.2 China Liposomes Drug Delivery Market Size and Market Share by Players (2016 and 2017)

9 India Liposomes Drug Delivery Development Status and Outlook
    9.1 India Liposomes Drug Delivery Market Size (2012-2017)
    9.2 India Liposomes Drug Delivery Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Liposomes Drug Delivery Development Status and Outlook
    10.1 Southeast Asia Liposomes Drug Delivery Market Size (2012-2017)
    10.2 Southeast Asia Liposomes Drug Delivery Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions and Application (2017-2022)
    11.1 Global Liposomes Drug Delivery Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Liposomes Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.2 EU Liposomes Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Liposomes Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.4 China Liposomes Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.5 India Liposomes Drug Delivery Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Liposomes Drug Delivery Revenue and Growth Rate (2017-2022)
    11.2 Global Liposomes Drug Delivery Market Size (Value) by Application (2017-2022)
    11.3 The Market Drivers in Future

12 Liposomes Drug Delivery Market Dynamics
    12.1 Liposomes Drug Delivery Market Opportunities
    12.2 Liposomes Drug Delivery Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Liposomes Drug Delivery Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Liposomes Drug Delivery Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Liposomes Drug Delivery Product Scope
    Figure Global Liposomes Drug Delivery Market Size (Million USD) (2012-2017)
    Table Global Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Liposomes Drug Delivery Market Share by Regions in 2016
    Figure United States Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Liposomes Drug Delivery Market Share by Application in 2016
    Table Key Downstream Customer in Fungal Infection Therapy
    Figure Liposomes Drug Delivery Market Size (Million USD) and Growth Rate in Fungal Infection Therapy (2012-2017)
    Table Key Downstream Customer in Cancer Therapy
    Figure Liposomes Drug Delivery Market Size (Million USD) and Growth Rate in Cancer Therapy (2012-2017)
    Figure Liposomes Drug Delivery Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)
    Table Liposomes Drug Delivery Market Size (Million USD) by Players (2016 and 2017)
    Figure Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure Liposomes Drug Delivery Market Size Share by Players in 2017
    Table Johnson & Johnson Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
    Figure Johnson & Johnson Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Gilead Sciences Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Gilead Sciences (2012-2017)
    Figure Gilead Sciences Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Luye Pharma Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Luye Pharma (2012-2017)
    Figure Luye Pharma Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Sun Pharmaceutical Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Sun Pharmaceutical (2012-2017)
    Figure Sun Pharmaceutical Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Pacira Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Pacira (2012-2017)
    Figure Pacira Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Fudan-Zhangjiang Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Fudan-Zhangjiang (2012-2017)
    Figure Fudan-Zhangjiang Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Sigma-Tau Group Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Sigma-Tau Group (2012-2017)
    Figure Sigma-Tau Group Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Teva Pharmaceutical Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Teva Pharmaceutical (2012-2017)
    Figure Teva Pharmaceutical Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table CSPC Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of CSPC (2012-2017)
    Figure CSPC Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Novartis Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Novartis (2012-2017)
    Figure Novartis Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Crucell Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Crucell (2012-2017)
    Figure Crucell Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Celsion Corporation Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Celsion Corporation (2012-2017)
    Figure Celsion Corporation Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Kingond Pharm Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Kingond Pharm (2012-2017)
    Figure Kingond Pharm Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Shanghai New Asia Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Shanghai New Asia (2012-2017)
    Figure Shanghai New Asia Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Spectrum Pharmaceuticals Basic Information List
    Table Liposomes Drug Delivery Business Revenue (Million USD) of Spectrum Pharmaceuticals (2012-2017)
    Figure Spectrum Pharmaceuticals Liposomes Drug Delivery Business Revenue Market Share in 2016
    Table Global Liposomes Drug Delivery Market Size (Million USD) by Application (2012-2017)
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2012
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2013
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2014
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2015
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2016
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Liposomes Drug Delivery
    Figure United States Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Liposomes Drug Delivery Market Size (Million USD) by Players (2012-2017)
    Figure United States Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure United States Liposomes Drug Delivery Market Size Share by Players in 2017
    Figure EU Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Liposomes Drug Delivery Market Size (Million USD) by Players (2012-2017)
    Figure EU Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure EU Liposomes Drug Delivery Market Size Share by Players in 2017
    Figure Japan Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Liposomes Drug Delivery Market Size (Million USD) by Players (2012-2017)
    Figure Japan Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure Japan Liposomes Drug Delivery Market Size Share by Players in 2017
    Figure China Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Liposomes Drug Delivery Market Size (Million USD) by Players (2012-2017)
    Figure China Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure China Liposomes Drug Delivery Market Size Share by Players in 2017
    Figure India Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Liposomes Drug Delivery Market Size (Million USD) by Players (2012-2017)
    Figure India Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure India Liposomes Drug Delivery Market Size Share by Players in 2017
    Figure Southeast Asia Liposomes Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Liposomes Drug Delivery Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Liposomes Drug Delivery Market Size Share by Players in 2016
    Figure Southeast Asia Liposomes Drug Delivery Market Size Share by Players in 2017
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Regions (2017-2022)
    Table Global Liposomes Drug Delivery Market Size (Million USD) by Regions (2017-2022)
    Figure Global Liposomes Drug Delivery Market Size Share by Regions in 2017
    Figure Global Liposomes Drug Delivery Market Size Share by Regions in 2022
    Figure United States Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Liposomes Drug Delivery Market Size (Million USD) by Application (2017-2022)
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2017
    Figure Global Liposomes Drug Delivery Market Size (Million USD) by Application in 2022